Keymed Biosciences, Inc. (HK:2162)
:2162
Want to see HK:2162 full AI Analyst Report?
Comparison Results
Keymed Biosciences, Inc.
HK$62.80
HK$17.22B
-8.22
50.59%
3 Buy
0 Hold
0 Sell
Strong Buy
Ascletis Pharma, Inc.
HK$18.48
HK$15.76B
-27.65
115.86%
1 Buy
1 Hold
0 Sell
Moderate Buy
Simcere Pharmaceutical Group Limited
HK$13.79
HK$27.13B
19.91
1.53%
3 Buy
0 Hold
0 Sell
Strong Buy
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$7.99B
9.33
0.22%
1 Buy
0 Hold
0 Sell
Moderate Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$10.20B
-82.36
-18.94%
1 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$20.67B
25.33
257.14%
―
Performance Comparison
HK:2162
Keymed Biosciences, Inc.
63.55
22.85
56.14%
HK:1672
Ascletis Pharma, Inc.
15.11
8.49
128.25%
HK:2096
Simcere Pharmaceutical Group Limited
10.60
0.43
4.23%
HK:2157
Lepu Biopharma Co. Ltd. Class H
4.48
0.18
4.19%
HK:2171
CARsgen Therapeutics Holdings Ltd.
17.51
-5.19
-22.86%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
51.00
36.34
247.89%